GAMMA Investing
KMTS icon

GAMMA Investing’s Kestra Medical Technologies KMTS Stock Holding History

GAMMA Investing’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$905 Buy
32
+22
+220% +$561 ﹤0.01% 4116
2026
Q2 		$254 Hold
10
– – ﹤0.01% 4065
2026
Q1 		$199 Sell
10
-8
-44% -$189 ﹤0.01% 4057
2025
Q4 		$477 Buy
+18
New +$464 ﹤0.01% 3919

Other funds holding KMTS

AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

GAMMA Investing's KMTS Position: Q3 2026 in Review

GAMMA Investing increased its Kestra Medical Technologies (KMTS) stake by 220% in Q3 2026, buying an estimated $561 and bringing the position to 32 shares worth $905. The position accounts for ﹤0.01% of the portfolio, ranked #4116.

GAMMA Investing first reported a position in KMTS in Q4 2025 and has held it in 4 quarters since. 6 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • GAMMA Investing held 32 shares of Kestra Medical Technologies worth $905 as of Q3 2026.
  • GAMMA Investing bought 22 Kestra Medical Technologies shares in Q3 2026, an estimated $561.
  • Kestra Medical Technologies made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4116 holding.
  • GAMMA Investing first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 4 quarters since.
  • 6 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.